B-cell agonists up-regulate AID and APOBEC3G deaminases, which induce IgA and IgG class antibodies and anti-viral function

Immunology

Volumn 135, Issue 3, 2012, Pages 207-215

  Seidl, Thomas ^a   Whittall, Trevor ^a   Babaahmady, Kaboutar ^a   Lehner, Thomas ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Activation induced cytidine deaminase; Apolipoprotein B mRNA editing enzyme catalytic polypeptide like 3G; B cell agonists; HIV infection

Indexed keywords

ACTIVATION INDUCED CYTIDINE DEAMINASE; APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3G; CD19 ANTIGEN; CD40 LIGAND; HLA ANTIBODY; HLA ANTIGEN CLASS 2; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; INTERLEUKIN 4;

ADAPTIVE IMMUNITY; ANTIBODY PRODUCTION; ANTIVIRAL ACTIVITY; ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNIZATION; INNATE IMMUNITY; NONHUMAN; PRIORITY JOURNAL; UPREGULATION; VIRUS INHIBITION; VIRUS REPLICATION;

ADAPTIVE IMMUNITY; ANTIVIRAL AGENTS; B-LYMPHOCYTES; BASE SEQUENCE; CD40 LIGAND; CYTIDINE DEAMINASE; HIV INFECTIONS; HIV-1; HUMANS; IMMUNITY, INNATE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN CLASS SWITCHING; IMMUNOGLOBULIN G; INTERLEUKIN-4; RNA, MESSENGER; UP-REGULATION;

EID: 84856159272     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2011.03524.x     Document Type: Article

References (29)

1. Harris RS, Sheehy AM, Craig HM, Malim MH, Neuberger MS. DNA deamination: not just a trigger for antibody diversification but also a mechanism for defense against retroviruses. Nat Immunol 2003; 4:641-3.
2. Petersen-Mahrt SK, Harris RS, Neuberger MS. AID mutates E. coli suggesting a DNA deamination mechanism for antibody diversification. Nature 2002; 418:99-103.
3. Conticello SG, Thomas CJ, Petersen-Mahrt SK, Neuberger MS. Evolution of the AID/APOBEC family of polynucleotide(deoxy)cytidine deaminases. Mol Biol Evol 2005; 22:367-77.
4. Stavnezer J, Guikema JEJ, Schrader CE. Mechanism and regulation of class switch recombination. Ann Rev Immunol 2008; 26:261-92.
5. Peled JU, Kuang FL, Iglesias-Ussel MD, Roa S, Kalis SL, Goodman MF, Scharff MD. The biochemistry of somatic hypermutation. Ann Rev Immunol 2008; 26:481-511.
6. Muramatsu M, Kinoshita K, Fagarasan S, Yamada S, Shinkai Y, Honjo T. Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell 2000; 102:553-63.
7. Chiu YL, Greene WC. The APOBEC3 cytidine deaminases: an innate defensive network opposing exogenous retroviruses and endogenous retroelements. Annu Rev Immunol 2008; 26:317-53.
8. Koning FA, Newman ENC, Kim E-Y, Kunstman KJ, Wolinsky SM, Malim MH. Defining APOBEC3 expression patterns in human tissues and hematopoietic cell subsets. J Virol 2009; 83:9474-85.
9. Khatua AK, Taylor HE, Hildreth JEK, Popik W. Exosomes packaging APOBEC3G confer human immunodeficiency virus resistance to recipient cells. J Virol 2009; 83:512-21.
10. McLellan AD. Exosome release by primary B cells. Crit Rev Immunol 2009; 29:203-17.
11. Cameron L, Gounni AS, Frenkiel S, Lavigne F, Vercelli D, Hamid Q. SεSμ and SεSγ switch circles in human nasal mucosa following ex vivo allergen challenge: evidence for direct as well as sequential class switch recombination. J Immunol 2003; 171:3816-22.
12. Turelli P, Trono D. Editing at the crossroad of innate and adaptive immunity. Science 2005; 307:1061-5.
13. Pauli E-K, Schmolke M, Hofmann H, Ehrhardt C, Flory E, Munk C, Ludwig S. High level expression of the anti-retroviral protein APOBEC3G is induced by influenza A virus but does not confer antiviral activity. Retrovirology. 2009; 6:38.
14. van der Neut Kolfschoten M, Schuurman J, Losen M et al. Anti-inflammatory activity of human IgG4 antibodies by dynamic Fab arm exchange. Science 2007; 317:1554-7.
15. Yates NL, Ashley VC, Lambotte O et al. Differential Regulation of HIV-Specific IgG Sublass Antibodies Following Infection Versus Vaccination. Boston: HIV Acute Infection Meeting, 2009.
16. + T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J Exp Med 2004; 200:749-59.
17. + T cells. Nature 2005; 434:1148-52.
18. + T lymphocytes from effector sites in the gastrointestinal tract. J Exp Med 2004; 200:761-70.
19. + T cells in multiple tissues during acute SIV infection. Nature 2005; 434:1093-7.
20. + memory T cells. Vaccine 2009; 527:870-81.
21. Sui Y, Zhu Q, Gagnon S et al. Innate and adaptive immune correlates of vaccine and adjuvant-induced control of mucosal transmission of SIV in macaques. Proc Natl Acad Sci USA 2010; 107:9843-8.
22. + T cells and dendritic cells. J Immunology 2007; 178:1671-9.
23. Karin M, Ben-Neriah Y. Phosphorylation meets ubiquitination: the control of NF-κB activity. Annu Rev Immunol 2000; 18:621-63.
24. Manis JP, Tian M, Alt FW. Mechanism and control of class-switch recombination. Trends Immunol 2002; 23:31-9.
25. Cerutti A. The regulation of IgA class switching. Nat Rev Immunol 2008; 8(6):421-34.
26. Tran TH, Nakata M, Suzuki K, Begum NA, Shinkura R, Fagarasan S, Honjo T, Nagaoka H. B cell-specific and stimulation-responsive enhancers depress Aicda by overcoming the effects of silencers. Nat Immunol 2010; 11:148-54.
27. Saunderson SC, Schuberth PC, Dunn AC et al. Induction of exosome release in primary B cells stimulated via CD40 and the IL-4 receptor. J Immunol 2008; 180:8146-52.
28. Arita S, Baba E, Yoshihiro S et al. B cell activation regulates exosomal HLA production. Eur J Immunol 2008; 38:1423-34.
29. Xu W, Santini PA, Sullivan JS et al. HIV-1 evades virus-specific IgG2 and IgA responses by targeting systemic and intestinal B cells via long-range intercellular conduits. Nat Immunol 2009; 10:1008-17.